LOADING
Comparing Johnson & Johnson (JNJ) and Comcast Corporation (CMCSA) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | CMCSA |
|---|---|---|
| Price | $270.24 | $26.85 |
| Change Today | +1.07% | +1.63% |
| Market Cap | $651.3B | $95.3B |
| P/E Ratio | 31.4 | 8.6 |
| Forward P/E | 23.2 | 7.7 |
| PEG Ratio | 4.73 | 2.39 |
| EPS | $8.62 | $3.12 |
| Revenue Growth (YoY) | 6.6% | -1.2% |
| Profit Margin | 21.5% | 9.0% |
| Return on Equity | 25.7% | 11.5% |
| Dividend Yield | 1.96% | 5.00% |
| Beta | 0.23 | 0.65 |
| 52-Week High | $276.47 | $32.05 |
| 52-Week Low | $170.33 | $21.28 |
| Volume | 6.2M | 20.3M |
Johnson & Johnson is the larger company by market capitalization. Comcast Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Comcast Corporation offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.